Flotek Industries announced a 27% increase in total revenues to $70.1 million for Q1 2026, led by a 295% jump in Data Analytics revenue and a 13% rise in Chemistry Technologies revenue. Data Analytics now contributes half of the company's gross profit, reflecting a strategic shift towards high-margin, recurring revenue streams like power services. Despite a 13% net income decline to $4.7 million due to higher taxes, adjusted EBITDA rose 44% to $9.1 million. Flotek projects 2026 revenues between $270 million and $290 million, with adjusted EBITDA of $36 million to $41 million, signaling strong growth prospects.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
Holtec Nuclear Corporation has filed a registration statement with the U.S. SEC for a proposed initial public offering (IPO) of its Class A common stock, planning to list on Nasdaq under the symbol "HNUC." The offering details, including share count ...
DeFi platform Aave introduced Stable Vaults, enabling fintechs and payment providers to offer fixed-rate stablecoin yields, enhancing its ecosystem. This launch, alongside the Aave V4 upgrade, increased token trading volume by 14.5% and price by near...
Morgan Stanley has filed to launch Ethereum and Solana ETFs with a competitive 0.14% management fee, aiming to capture market share as crypto ETFs become more commoditized. These ETFs will offer direct token exposure, staking rewards, and institution...
